Skip to content

The Influence of Personality Characteristics on the Results of the FASTER-SCOTT Study

The Influence of Personality Characteristics on the Results of the FASTER-SCOTT Study

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
DRKS
Registry ID
DRKS00039707
Enrollment
360
Registered
2026-03-26
Start date
2021-03-10
Completion date
Unknown
Last updated
2026-03-30

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Autism-Spectrum-Disorder: F84.0, F84.1, F84.5 F84.0 F84.1 F84.5

Interventions

Group 1: Treatment as usual (TAU) Group 2: SCOTT&EVA is a software-based training program for recognizing 40 different emotions from facial expressions, tone of voice, and complex social situations. A

Sponsors

Klinik für Psaychiatrie und Psychotherapie, Universitätsklinikum Freiburg, Medizinische Fakultät
Lead Sponsor

Eligibility

Sex/Gender
All
Age
18 Years to 65 Years

Inclusion criteria

Inclusion criteria: (+) ASD (ICD-10: F84.0, F84.5 or F84.1 (provided DSM criterion A, social communication and social interaction, is met) (+) Age between 18 and 65 (+) IQ of at least 80 (+) Relevant psychosocial difficulties (global functioning level (GAF) score = 60) (+) Fluent German language skills of the study participants and parents/partners/other close persons, so that they can complete the questionnaire and understand the instructions (+) Ability of the study participants to understand the nature and individual consequences of the clinical study (+) Signed informed consent (+) Sufficient ability to communicate in groups (+) Reading and writing without significant impairment (+) No or stable psychopharmacological treatment (+) Presence of a person who can complete the informant questionnaire SRS-A (parent/partner/other close person)

Exclusion criteria

Exclusion criteria: (–) Psychiatric comorbid disorders: acute (florid) psychosis, acute (florid) schizophrenia, acute bipolar or other neurological disorder, acute severe depression, acute suicidality (–) Substance abuse / substance dependence within the last 12 months (–) Current or past gambling addiction (–) Uncorrected severe visual or hearing impairment (–) Severe group-disruptive behavior in the past (–) Any neurological disease or medical condition that is incompatible with group therapy (–) Group-oriented social skills training or other structured psychotherapy targeting the core symptoms of ASD (currently or in the last 6 months prior to study start; structured psychotherapy for comorbid disorders is allowed) (–) Inpatient clinical stay at T0

Design outcomes

Primary

MeasureTime frame
SRS-A self-assessment, change four months after randomization, or after the sixteen therapy sessions over four months

Secondary

MeasureTime frame
(1a) Difference in overall sum change of the SRS-A, external assessment (1b) Difference in change between external and self-description in the five subscales of the SRS-A (1c) Difference in change of the modified SRS-A for the overall sum and the five subscales for external and self-description (2) General psychiatric well-being [Depression: BDI-II, global functional level: GAF, social anxiety and deficits in social skills: SASKO]

Countries

Germany

Contacts

Public ContactLudger Tebartz van Elst

Universitätsklinikum Freiburg, Medizinische Fakultät, Klinik für Psychiatrie und Psychotherapie

tebartzvanelst@uniklinik-freiburg.de+49 761- 270 660 30

Outcome results

None listed

Source: DRKS (via WHO ICTRP) · Data processed: Apr 4, 2026